Credit Suisse’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-120,563
| Closed | -$6.44M | – | 4084 |
|
|
2016
Q1 | $6.44M | Buy |
120,563
+32,220
| +36% | +$1.72M | 0.01% | 1234 |
|
|
2015
Q4 | $9.98M | Sell |
88,343
-21,280
| -19% | -$2.4M | 0.01% | 1056 |
|
|
2015
Q3 | $12.9M | Sell |
109,623
-75,060
| -41% | -$8.84M | 0.02% | 916 |
|
|
2015
Q2 | $14.3M | Buy |
184,683
+27,381
| +17% | +$2.12M | 0.01% | 938 |
|
|
2015
Q1 | $9.1M | Sell |
157,302
-21,733
| -12% | -$1.26M | 0.01% | 1133 |
|
|
2014
Q4 | $5.77M | Buy |
179,035
+27,350
| +18% | +$882K | 0.01% | 1417 |
|
|
2014
Q3 | $3.71M | Buy |
151,685
+50,584
| +50% | +$1.24M | ﹤0.01% | 1708 |
|
|
2014
Q2 | $1.79M | Buy |
101,101
+5,073
| +5% | +$89.9K | ﹤0.01% | 2450 |
|
|
2014
Q1 | $1.92M | Buy |
96,028
+5,646
| +6% | +$113K | ﹤0.01% | 2233 |
|
|
2013
Q4 | $1.52M | Buy |
90,382
+3,649
| +4% | +$61.2K | ﹤0.01% | 2543 |
|
|
2013
Q3 | $921K | Buy |
86,733
+52,226
| +151% | +$555K | ﹤0.01% | 2642 |
|
|
2013
Q2 | $193K | Buy |
+34,507
| New | +$193K | ﹤0.01% | 3473 |
|